# Study of the Effects of Brilacidin Oral Rinse on Radiation-induced Oral Mucositis in Patients With Head and Neck Cancer

> **NCT02324335** · PHASE2 · COMPLETED · sponsor: **Innovation Pharmaceuticals, Inc.** · enrollment: 61 (actual)

## Conditions studied

- Head and Neck Neoplasms
- Mucositis

## Interventions

- **DRUG:** Brilacidin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02324335
- **Lead sponsor:** Innovation Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08-14
- **Primary completion:** 2017-10-25
- **Final completion:** 2017-11-22
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2019-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02324335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02324335, "Study of the Effects of Brilacidin Oral Rinse on Radiation-induced Oral Mucositis in Patients With Head and Neck Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02324335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*